TriMas Corporation — Q3 2013 Form 10-Q Summary
Business context and reporting period
TriMas is a global manufacturer and distributor serving commercial, industrial and consumer markets through six segments: Packaging, Energy, Aerospace & Defense, Engineered Components, Cequent APEA and Cequent Americas. The filing covers the unaudited three and nine months ended September 30, 2013, compared with the corresponding 2012 periods.
Key financial metrics
| Metric | Q3 2013 | Q3 2012 | 9M 2013 | 9M 2012 |
|---|---|---|---|---|
| Net sales | $355.6 million | $335.9 million | $1,071.4 million | $971.9 million |
| Gross profit | $94.2 million | $90.1 million | $280.9 million | $264.9 million |
| Gross margin | 26.5% | 26.8% | 26.2% | 27.3% |
| Operating profit | $43.3 million | $36.6 million | $108.7 million | $108.5 million |
| Operating margin | 12.2% | 10.9% | 10.1% | 11.2% |
| Net income attributable to TriMas | $28.6 million | $18.7 million | $68.7 million | $47.8 million |
| Diluted EPS | $0.70 | $0.47 | $1.72 | $1.28 |
For the first nine months, net cash provided by operating activities was $41.3 million, versus $15.4 million in 2012. Capital expenditures were $35.2 million and acquisitions used $56.0 million. Cash and cash equivalents increased to $209.4 million at September 30, 2013, from $20.6 million at December 31, 2012.
Total debt was $479.7 million, including $21.6 million of current maturities, compared with $422.4 million at year-end 2012. The company had $55.0 million outstanding under its $105.0 million accounts receivable facility and $20.7 million outstanding under its revolving credit facility. Borrowing capacity available for general corporate purposes was $206.6 million after leverage restrictions. The company was in compliance with its debt covenants; actual leverage was 2.47x versus a 3.50x limit, and interest coverage was 9.82x versus a 3.00x requirement.
Material changes versus the prior comparable period
- Q3 sales increased 5.9%; nine-month sales increased 10.2%. Acquisitions contributed approximately $17.2 million of Q3 sales growth and $57.7 million of nine-month growth.
- Q3 operating profit increased 18.3%, primarily because of a $10.5 million pretax gain on the sale of the Italian Packaging business. The gain included a $7.9 million release of accumulated foreign-currency translation adjustments.
- Nine-month operating profit was essentially flat despite higher sales, as lower-margin acquired businesses, integration and growth costs, facility relocation costs and unfavorable product mix offset sales growth.
- Interest expense declined to $5.6 million in Q3 and $16.3 million for the nine months, from $9.5 million and $30.4 million, respectively, primarily because of the 2012 refinancing and retirement of higher-cost senior secured notes.
- Gross margins declined year over year, reflecting acquisition mix, manufacturing inefficiencies and Cequent footprint-consolidation costs. Q3 gross margin was broadly stable; the nine-month decline was more pronounced.
- Packaging and Aerospace & Defense reported strong sales growth. Energy, Engineered Components and Cequent segments experienced margin pressure; Engineered Components sales declined 8.4% in Q3 and 6.7% for the nine months.
- The company issued 5.175 million common shares in September 2013 for net proceeds of approximately $174.7 million, primarily for general corporate purposes, acquisitions, capital expenditures and working capital.
Guidance, outlook, risks and unusual items
Management did not provide a specific numerical revenue or earnings guidance target in the filing. Management expected continued growth from acquisitions, market-share gains, new products, international expansion and productivity initiatives, while acknowledging near-term margin pressure from integration costs, lower-margin acquisitions and Cequent facility moves. Management expected margins to improve toward historical levels as businesses were integrated and productivity and volume efficiencies developed.
- Approximately $4.8 million of Cequent manufacturing inefficiency, facility-move and duplicate costs were incurred in Q3, and approximately $6.4 million in the first nine months. The Goshen, Indiana facility closure involved severance costs and was expected to generate additional accelerated depreciation and future lease-obligation charges.
- The company completed approximately $56 million of acquisitions during the first nine months, including Martinic, Wulfrun, Witter and AL-KO-related assets. In October 2013, it acquired Mac Fasteners for approximately $34 million plus potential contingent consideration of up to approximately $6 million.
- In October 2013, TriMas refinanced its credit facilities with a $575 million revolving facility and a $175 million term loan A, both maturing October 16, 2018 and initially priced at LIBOR plus 1.625%. The refinancing reduced interest rates, extended maturities and increased liquidity.
- Key operating risks include cyclical and competitive end markets, consumer demand in Cequent, raw-material and energy costs, foreign-exchange volatility, acquisition integration, facility-consolidation execution and variable-rate debt exposure.
- At September 30, 2013, 1,078 asbestos cases involving 7,950 claimants were pending. Management did not believe the litigation would materially affect financial position, results or cash flows, but noted possible future defense and settlement costs and a potential period of reduced insurance coverage.
- Foreign-currency translation reduced other comprehensive income by $12.5 million for the first nine months. A 1% increase in applicable interest rates was estimated to increase annual interest expense by approximately $0.6 million.
Important facts for investors to verify
- Whether the October 2013 refinancing produced the expected interest savings and liquidity improvement.
- Progress, remaining costs and operational benefits from the Goshen closure and Cequent footprint-consolidation projects.
- Whether acquired businesses achieve targeted margins and integration synergies without additional purchase-accounting or restructuring costs.
- Trends in Engineered Components demand, Energy turnaround activity and Cequent consumer and international markets.
- Working-capital conversion, particularly receivables growth and cash flow relative to reported earnings.
- Future asbestos defense, settlement and insurance costs, including the timing of excess insurance coverage.
- The final working-capital adjustments for the Italian business sale and 2013 acquisitions, and any contingent consideration related to Mac Fasteners.